Lee Peter T, Benlagha Kamel, Teyton Luc, Bendelac Albert
Department of Molecular Biology, Princeton University, Princeton, NJ 08544, USA.
J Exp Med. 2002 Mar 4;195(5):637-41. doi: 10.1084/jem.20011908.
CD1d-restricted autoreactive natural killer (NK)T cells have been reported to regulate a range of disease conditions, including type I diabetes and immune rejection of cancer, through the secretion of either T helper (Th)2 or Th1 cytokines. However, mechanisms underlying Th2 versus Th1 cytokine secretion by these cells are not well understood. Since most healthy subjects express <1 NKT cell per 1,000 peripheral blood lymphocytes (PBLs), we devised a new method based on the combined used of T cell receptor (TCR)-specific reagents alpha-galactosylceramide (alphaGalCer) loaded CD1d-tetramers and anti-V(alpha)24 monoclonal antibody, to specifically identify and characterize these rare cells in fresh PBLs. We report here that CD4(+) and CD4(-)CD8(-) (double negative [DN]) NKT cell subsets represent functionally distinct lineages with marked differences in their profile of cytokine secretion and pattern of expression of chemokine receptors, integrins, and NK receptors. CD4(+) NKT cells were the exclusive producers of interleukin (IL)-4 and IL-13 upon primary stimulation, whereas DN NKT cells had a strict Th1 profile and prominently expressed several NK lineage receptors. These findings may explain how NKT cells could promote Th2 responses in some conditions and Th1 in others, and should be taken into consideration for intervention in relevant diseases.
据报道,受CD1d限制的自身反应性自然杀伤(NK)T细胞可通过分泌辅助性T细胞(Th)2或Th1细胞因子来调节一系列疾病状态,包括I型糖尿病和癌症的免疫排斥反应。然而,这些细胞分泌Th2与Th1细胞因子的潜在机制尚不清楚。由于大多数健康受试者每1000个外周血淋巴细胞(PBL)中表达的NKT细胞少于1个,我们设计了一种基于联合使用负载α-半乳糖神经酰胺(αGalCer)的T细胞受体(TCR)特异性试剂CD1d四聚体和抗V(α)24单克隆抗体的新方法,以特异性识别和表征新鲜PBL中的这些稀有细胞。我们在此报告,CD4(+)和CD4(-)CD8(-)(双阴性[DN])NKT细胞亚群代表功能上不同的谱系,它们在细胞因子分泌谱、趋化因子受体、整合素和NK受体的表达模式上存在显著差异。初次刺激时,CD4(+)NKT细胞是白细胞介素(IL)-4和IL-13的唯一产生者,而DN NKT细胞具有严格的Th1谱并显著表达几种NK谱系受体。这些发现可能解释了NKT细胞如何在某些情况下促进Th2反应而在其他情况下促进Th1反应,并且在干预相关疾病时应予以考虑。